Surgical treatment of liver metastases of gastric cancer: state of the art. (Q38031998)

27 August 2017

1 reference

3 April 2019

Surgical treatment of liver metastases of gastric cancer: state of the art. (English)

1 reference

27 August 2017

1 reference

3 April 2019

1 reference

3 April 2019

Fabio Uggeri

3

1 reference

ORCID Public Data File 2021

author name string

Fabrizio Romano

1

1 reference

27 August 2017

Mattia Garancini

2

1 reference

27 August 2017

Luca Degrate

4

1 reference

27 August 2017

Luca Nespoli

5

1 reference

27 August 2017

Luca Gianotti

6

1 reference

27 August 2017

Angelo Nespoli

7

1 reference

27 August 2017

Franco Uggeri

8

1 reference

27 August 2017

language of work or name

1 reference

3 August 2012

3 references

World Journal of Surgical Oncology

27 August 2017

21 March 2019

3 April 2019

1 reference

27 August 2017

10

1 reference

27 August 2017

157

1 reference

Creative Commons Attribution 2.0 Generic

27 August 2017

2 references

21 March 2019

on focus list of Wikimedia project

3 April 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1477-7819-10-157

0 references

cites work

Treatment of resectable gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Gastric cancer epidemiology in Korea

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Current status and progress in gastric cancer with liver metastasis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Liver resections in metastatic gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Surgery for colorectal liver metastases.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Strategies for treating liver metastasis from gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

6 September 2017

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Metachronous hepatic metastases from gastric carcinoma: a multicentric survey

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Major hepatectomy for isolated metastases from gastric adenocarcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Management of liver metastases from colorectal cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Prognostic factors for noncurative gastric cancer: univariate and multivariate analyses

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Epidemiology of noncardia gastric adenocarcinoma in the United States.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Radiofrequency ablation for metachronous hepatic metastases from gastric cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Intrahepatic micrometastases around liver metastases from gastric cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Liver resection for metastatic gastric cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Survival of gastric cancer with concomitant liver metastases.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) is more active than 5-fluorouracil, doxorubicin and methotrexate (FAMTX) in advanced gastric carcinoma

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3490926

Benefits and limits of hepatic resection for gastric metastases

31 August 2018

1 reference

12 December 2020

Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer

1 reference

12 December 2020

Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors

1 reference

12 December 2020

The role of hepatectomy for patients with liver metastases of gastric cancer

1 reference

12 December 2020

Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer

1 reference

12 December 2020

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

12 December 2020

Prognostic studies on gastric cancer with concomitant liver metastases

1 reference

12 December 2020

Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors

1 reference

12 December 2020

Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors

1 reference

12 December 2020

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

1 reference

12 December 2020

Hepatic resection of liver metastases from gastric carcinoma

1 reference

12 December 2020

Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model

1 reference

12 December 2020

Hepatic resection for metastatic tumors from gastric cancer

1 reference

12 December 2020

A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma

1 reference

12 December 2020

Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients

1 reference

12 December 2020

Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma

1 reference

12 December 2020

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

1 reference

12 December 2020

Resection of liver metastasis from gastric adenocarcinoma

1 reference

12 December 2020

Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results

1 reference

12 December 2020

Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients

1 reference

12 December 2020

Outcome of hepatic resection for metastatic gastric cancer

1 reference

12 December 2020

Indication for hepatic resection in the treatment of liver metastasis from gastric cancer

1 reference

12 December 2020

Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7819-10-157

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference

27 August 2017

PubMed publication ID

22862882

1 reference